Catheter Precision Board Approves Rebranding To Flyte Aviation And 1-For-10 Reverse Stock Split, Effective October 5, 2026
On September 24, 2026, the Board of Directors (the "Board") of Catheter Precision, Inc. (the "Company") approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to (i) change the Company's name from "Catheter Precision, Inc." to "Flyte Aviation, Inc." (the "Name Change"), and (ii) effect a 1-for-10 reverse stock split of the Company's common stock, par value $0.0001 per share (the "Common Stock") (the "Reverse Stock Split"). The Name Change was approved by the Board pursuant to Section 242(b)(1) of the General Corporation Law of the State of Delaware and did not require stockholder approval. The Company's stockholders approved the Reverse Stock Split at a special meeting held on April 15, 2026, and the Board selected the ratio within the range approved by the stockholders. The Company intends to file a certificate of amendment with the Secretary of State of the State of Delaware to effect the Name Change and the Reverse Stock Split, which are expected to become effective at 12:01 a.m., Eastern Time, on October 5, 2026 (the "Effective Time"). At the Effective Time, every ten (10) shares of Common Stock issued and outstanding or held in tr
On September 24, 2026, the Board of Directors (the "Board") of Catheter Precision, Inc. 0001 per share (the "Common Stock") (the "Reverse Stock Split"). The Name Change was approved by the Board pursuant to Section 242(b)(1) of the General Corporation Law of the State of Delaware and did not require stockholder approval. The Company's stockholders approved the Reverse Stock Split at a special meeting held on April 15, 2026, and the Board selected the ratio within the range approved by the stockholders.
, Eastern Time, on October 5, 2026 (the "Effective Time"). At the Effective Time, every ten (10) shares of Common Stock issued and outstanding or held in treasury will automatically be combined into one (1) share of Common Stock. No fractional shares will be issued. Stockholders who would otherwise be entitled to a fractional share will instead be entitled to receive their pro rata portion of the net proceeds from the aggregation and sale of such fractional shares by the Company's exchange agent.
The Reverse Stock Split will not change the par value of the Common Stock or the number of authorized shares of Common Stock, and proportionate adjustments will be made to the Company's outstanding equity awards, warrants, and convertible securities in accordance with their terms.